Advancing Care in Lupus Nephritis: Expert Perspectives on Current Practices and Future Directions in Italy. (PubMed, J Clin Med) - May 28, 2026 - " The authors highlight evolving treatment paradigms-shifting from traditional induction-maintenance strategies to early combination regimens integrating biologics such as belimumab and calcineurin inhibitors like voclosporin-aligned with updated EULAR and KDIGO guidelines. Emerging agents, including obinutuzumab, anifrolumab, and CAR-T cell therapies, represent promising advances toward steroid-sparing and potentially curative strategies. Continued research, biomarker development, and application of artificial intelligence are pivotal to optimizing outcomes and achieving personalized LN management."
IO biomarker • Journal • Review • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Rheumatology • Systemic Lupus Erythematosus
|
|
Andrea Doria; Dario Roccatello; Franco Franceschini; Gabriella Moroni; Loreto Gesualdo; Marta Mosca; Renato Alberto Sinico
|